As technologies and strategic partnerships rewrite the rules of business in biotech, biomedical engineering, and medical device design, biotechnology and pharmaceutical companies are under immense pressure to keep up a frenetic pace of innovation. Profitability is rising, yet the industry struggles to navigate a complicated maze of regulatory and financial hurdles.
Organizations in the biotechnology and pharmaceutical industry rely on Lewis Roca to protect their most important assets: their innovations. Having worked closely with numerous research and academic institutions as well as corporations and startups, our intellectual property lawyers have the wide-ranging experience and the technical know-how to help translate cutting-edge technologies into marketable products.
Our experience acquiring meaningful protection extends to a wide variety of disciplines, from therapeutics to pharmaceuticals, medical devices diagnostics, genetics, stem cell methodologies, antibodies, and dietary supplements. We complement that experience with constant monitoring of legal developments as well as the ever-changing standards of the United States Patent and Trademark Office, enabling us to serve as effective advocates for our clients.
Latest from Lewis Roca
- Press Release |  11/5/2020
- Press Release |  08/20/2020
- Press Release |  04/24/2020